Sales

How US healthcare reform could change pharma

Healthcare reform has made change in the pharma sector all the more urgent. Is the industry right to take a wait-and-see approach? Andrew Tolve investigates. read...

The future of pharma: managing complex markets

Pharma execs need to discard conventional thinking and prepare their organizations for bursts of sudden, dramatic change, argues Brian Smith. read...

What’s next for sales reps?

Marcus Deans explains why summer’s here and the time is right for ... rethinking the future of the sales rep. read...

Mal’s Musings: What’s Up with The Bottom Line?

Upon reflection, there are a number of misconceptions in business and many more ideas, concepts, and scenarios better categorized as bullsh_t.read...

New sales models and market access

John Ferguson explores new ways to update pharma sales methods to improve market access. read...

The future of pharma

Brian Smith explores what the history of the pharma industry says about what’s to come. read...

The impact of value mining on market access

Peter Mansell explains how multiple stakeholders are analyzing data to make their own determinations of medicine value. read...

Personalized medicine comes one step closer

Researchers from the Stanford University School of Medicine have given us a glimpse of what the future of healthcare could look like. read...

Dealing with Troubled Employees

Has one of the people who report to you recently made you angry or frustrated?read...

Pharma sales: How emotions impact prescribing behavior

Andrew Tolve reports on how motivational research can reveal the emotional factors that influence physicians’ prescription decisions  read...
Get Adobe Flash playerPlugin by wpburn.com wordpress themes